文献速递重症综合管理与镇静镇痛创伤与烧伤

重症创伤与外科患者肠内蛋白补充:单中心随机临床试验

Enteral protein supplementation in critically ill trauma and surgical patients: A single-center randomized clinical trial.
PubMed 文献 · J Trauma Acute Care Surg · 2025-07-17
一句话结论重症创伤与外科患者肠内蛋白补充至2 g/kg/d未改善转甲状腺素蛋白浓度或无呼吸机天数,且与再插管增加相关。

该单中心随机临床试验纳入500例以创伤为主(86%)、男性为主(77%)的重症创伤与外科患者,随机分为目标肠内蛋白2 g/kg/d的治疗组或标准营养治疗组。治疗组前7天实际平均蛋白摄入为1.2 ± 0.65 g/kg/d,对照组为0.6 ± 0.39 g/kg/d(p < 0.001)。主要终点方面,两组转甲状腺素蛋白浓度均值差为0.8 mg/dL(95%CI -1.3至2.8,p=0.46),无呼吸机天数均值差为-1.1(95%CI -2.8至0.6,p=0.21),均无显著差异。接受补充蛋白者血尿素氮更高,且更可能需要再插管。作者结论认为蛋白补充未改善结局,但与并发症增加相关。

要点

  • 重症创伤与外科患者肠内蛋白补充至目标2 g/kg/d,前7天实际平均1.2 ± 0.65 g/kg/d,对照组0.6 ± 0.39 g/kg/d(p < 0.001)。
  • 转甲状腺素蛋白浓度均值差0.8 mg/dL(95%CI -1.3至2.8,p=0.46),无呼吸机天数均值差-1.1(95%CI -2.8至0.6,p=0.21),均无显著差异。
  • 接受补充蛋白者血尿素氮浓度更高,且更可能需要再插管。
  • 作者结论:在该人群中蛋白补充未改善结局,但与并发症增加相关。

适用人群与场景

  • 重症创伤与外科患者,随机化时处于重症监护阶段,随访至出院。
  • 纳入人群以男性(77%)和创伤性损伤(86%)为主,中位年龄47岁。

处置流程与药物剂量

  • 治疗组目标为经肠内途径提供2 g/kg/d蛋白;前7天实际平均摄入1.2 ± 0.65 g/kg/d。
  • 对照组接受标准营养治疗;前7天实际平均蛋白摄入0.6 ± 0.39 g/kg/d。

研究设计与关键结果

  • 单中心随机临床试验,纳入500例重症创伤与外科患者,随机分为目标肠内蛋白2 g/kg/d组或标准营养治疗组。
  • 前7天平均蛋白摄入:治疗组1.2 ± 0.65 g/kg/d vs 对照组0.6 ± 0.39 g/kg/d(p < 0.001)。
  • 转甲状腺素蛋白浓度(ICU入住后14至21天)均值差0.8 mg/dL(95%CI -1.3至2.8,p=0.46),无显著差异。
  • 无呼吸机天数均值差-1.1(95%CI -2.8至0.6,p=0.21),无显著差异。
  • 接受补充蛋白者血尿素氮浓度更高,且更可能需要再插管。

证据类型、等级与局限

  • 证据类型:单中心随机临床试验;证据等级:治疗/照护管理,Level II。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,在该重症创伤与外科人群中进行蛋白补充未改善结局,但与并发症增加相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Critically ill trauma and surgical patients are highly catabolic, with expected high protein needs. However, there is uncertainty regarding the amount of protein required to optimize their outcomes. We conducted a single-center, randomized clinical trial to test the hypothesis that supplementing enteral protein intake would improve outcomes.

METHODS: Between November 15, 2016, and November 26, 2021, critically ill trauma and surgical patients were randomized either to a treatment arm aimed to deliver 2 g/kg/d of enteral protein or to standard nutritional care. Data were collected and subjects were followed until hospital discharge. Serum transthyretin concentration 14 to 21 days following intensive care unit admission and ventilator-free days were prespecified endpoints.

RESULTS: We randomized 500 subjects who were predominantly male (77%), suffered traumatic injuries (86%), and had a median age of 47 years. Those in the treatment arm received twice the amount of protein than those in the control arm (1.2 ± 0.65 g/kg/d vs. 0.6 ± 0.39 g/kg/d averaged over the first 7 days of hospitalization; p < 0.001). We observed no significant difference in mean transthyretin concentrations (difference of means, 0.8 mg/dL; 95% confidence interval, -1.3 to 2.8; p value = 0.46) or ventilator-free days (difference of means, -1.1; 95% confidence interval, -2.8 to 0.6; p value = 0.21). Participants receiving supplemental protein had higher blood urea nitrogen concentrations and were more likely to require reintubation.

CONCLUSION: In this clinical trial of critically ill trauma and surgical patients, protein supplementation did not improve outcomes but was associated with increased complications.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. O'Keefe GE, Brown SP, Shelton MM, et al. Enteral protein supplementation in critically ill trauma and surgical patients: A single-center randomized clinical trial. J Trauma Acute Care Surg. 2025. PMID: 40671181. doi:10.1097/TA.0000000000004745

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。